Arhanti Sadanand

422 total citations
16 papers, 275 citations indexed

About

Arhanti Sadanand is a scholar working on Neurology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Arhanti Sadanand has authored 16 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Arhanti Sadanand's work include Neuroblastoma Research and Treatments (5 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Arhanti Sadanand is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). Arhanti Sadanand collaborates with scholars based in United States, India and Canada. Arhanti Sadanand's co-authors include Chinnaperumal Kamaraj, James M. Tielsch, Lakshmi Rahmathullah, Karthik Prakash, Joanne Katz, Christian Coles, R.D. Thulasiraj, Jason G. Newland, Jeffrey J. Bednarski and V. Dhanda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and BMC Medical Education.

In The Last Decade

Arhanti Sadanand

15 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arhanti Sadanand United States	7	120	77	51	48	45	16	275
J. Delogne‐Desnoeck Belgium	9	150 1.3×	102 1.3×	46 0.9×	124 2.6×	49 1.1×	14	401
Emma de Jong Australia	12	71 0.6×	40 0.5×	65 1.3×	88 1.8×	34 0.8×	30	387
Michel Rolland France	10	39 0.3×	128 1.7×	59 1.2×	77 1.6×	35 0.8×	32	398
Rym Ben-Othman Canada	8	42 0.3×	20 0.3×	51 1.0×	47 1.0×	51 1.1×	19	214
Chandrawati Chandrawati India	9	121 1.0×	98 1.3×	22 0.4×	46 1.0×	63 1.4×	16	429
Gantira Natadisastra United States	11	214 1.8×	48 0.6×	215 4.2×	45 0.9×	75 1.7×	18	596
Luis Rodríguez Mexico	10	53 0.4×	78 1.0×	26 0.5×	24 0.5×	78 1.7×	30	301
Collin C. McCourt United States	7	53 0.4×	16 0.2×	68 1.3×	59 1.2×	25 0.6×	11	243
Jolanta Lis-Kuberka Poland	10	203 1.7×	21 0.3×	102 2.0×	126 2.6×	21 0.5×	24	444
Mary A Uyoga Switzerland	12	348 2.9×	27 0.4×	129 2.5×	50 1.0×	33 0.7×	18	562

Countries citing papers authored by Arhanti Sadanand

Since Specialization

Citations

This map shows the geographic impact of Arhanti Sadanand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arhanti Sadanand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arhanti Sadanand more than expected).

Fields of papers citing papers by Arhanti Sadanand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arhanti Sadanand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arhanti Sadanand. The network helps show where Arhanti Sadanand may publish in the future.

Co-authorship network of co-authors of Arhanti Sadanand

This figure shows the co-authorship network connecting the top 25 collaborators of Arhanti Sadanand. A scholar is included among the top collaborators of Arhanti Sadanand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arhanti Sadanand. Arhanti Sadanand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stutzman, Sonja E., MinJae Lee, Avanthi Tayi Shah, et al.. (2025). Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors. Pediatric Blood & Cancer. 72(12). e32046–e32046.

Cash, Thomas F., Jan H. Beumer, Arhanti Sadanand, et al.. (2023). A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatric Blood & Cancer. 70(8). e30405–e30405. 10 indexed citations

Sadanand, Arhanti, et al.. (2023). A single‐center retrospective review of pediatric cases of progressive transformation of germinal centers. Pediatric Blood & Cancer. 70(6). e30283–e30283. 2 indexed citations

Sadanand, Arhanti, Victor Maximov, Suttipong Suttapitugsakul, et al.. (2023). Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Reports Medicine. 4(6). 101091–101091. 12 indexed citations

Lerman, Benjamin, Yimei Li, Meaghan Granger, et al.. (2022). Progression-free survival and patterns of response in patients with high-risk neuroblastoma (HR-NB) treated with irinotecan/temozolomide/dinutuximab/granulocyte-macrophage colony-stimulating factor (I/T/DIN/GM-CSFS) chemoimmunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 10025–10025. 1 indexed citations

Sadanand, Arhanti, et al.. (2021). Teaching scripts via smartphone app facilitate resident-led teaching of medical students. BMC Medical Education. 21(1). 331–331. 3 indexed citations

Sadanand, Arhanti, Victor Maximov, Jasmine Lee, et al.. (2021). Abstract 3034: Proteomic profiling identifies PTK7 as a novel immunotherapeutic candidate for neuroblastoma. Cancer Research. 81(13_Supplement). 3034–3034. 1 indexed citations

Papanicolaou, Genovefa A., Christopher C. Dvorak, Sanjeet Dadwal, et al.. (2020). Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States. Transplant Infectious Disease. 22(4). e13283–e13283. 10 indexed citations

Sadanand, Arhanti, Jason G. Newland, & Jeffrey J. Bednarski. (2019). Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients. Infectious Diseases and Therapy. 8(2). 301–306. 27 indexed citations

10.

Chen, Stephanie, Arhanti Sadanand, Patrick A. Dillon, et al.. (2019). Non-Neural (S-100 Negative) Bronchial Granular Cell Tumor Causing Acute Respiratory Failure. Fetal and Pediatric Pathology. 39(1). 85–89. 6 indexed citations

11.

Sadanand, Arhanti, et al.. (2018). Development of a Medical Spanish Curriculum for Fourth-Year Medical Students. PRiMER. 2. 17–17. 8 indexed citations

12.

Rahmathullah, Lakshmi, James M. Tielsch, R.D. Thulasiraj, et al.. (2003). Impact of supplementing newborn infants with vitamin A on early infant mortality: community based randomised trial in southern India. BMJ. 327(7409). 254–254. 158 indexed citations

13.

Sadanand, Arhanti, et al.. (1996). Impact of deltamethrin spraying on malaria transmission in Rameshwaram Island, Tamil Nadu State - India.. PubMed. 28(1). 38–44. 2 indexed citations

14.

Ilango, K., V. Dhanda, R Srinivasan, Arhanti Sadanand, & R. P. Lane. (1994). Phlebotomine sandflies (Diptera: Psychodidae) of Tamil Nadu and Pondicherry, southern India, in relation to visceral leishmaniasis. Annals of Tropical Medicine and Parasitology. 88(4). 413–431. 30 indexed citations

15.

Sundaram, R. M., Arhanti Sadanand, & G. Narayanasamy. (1989). Susceptibility status of vectors of Japanese encephalitis to insecticides in south Arcot and Tirunelveli districts of Tamil Nadu.. PubMed. 21(3). 218–21. 1 indexed citations

16.

Sadanand, Arhanti. (1971). Biochemical analyses of the cyst wall of Echinococcus granulosus batsch. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 40(3). 797–805. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact